Sangamo Therapeutics Inc (SGMO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.44
• Market Cap: $174.69M
• EPS: $-0.45
• 52-Week High: $1.06
• 52-Week Low: $0.34

Market Sentiment

Sangamo Therapeutics Inc currently has a Bullish sentiment score of 0.23.

About Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is a clinical-stage biotechnology firm headquartered in Brisbane, California, specializing in the development of transformative genomic medicines. Utilizing its innovative platform technologies in gene therapy, cell therapy, genome editing, and genome regulation, Sangamo is dedicated to addressing unmet medical needs and improving patient outcomes. The company's cutting-edge research focuses on advancing therapies for genetic and acquired diseases, positioning it as...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sangamo Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SGMO pay dividends?

Sangamo Therapeutics Inc (SGMO) does not currently pay a regular dividend.

What is SGMO's market cap?

Sangamo Therapeutics Inc (SGMO) has a market capitalization of $174.69M with a current stock price of $0.44.